Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
258.75
-1.52 (-0.58%)
At close: Mar 28, 2025, 4:00 PM
261.86
+3.11 (1.20%)
After-hours: Mar 28, 2025, 7:17 PM EDT
Insulet Revenue
In the year 2024, Insulet had annual revenue of $2.07B with 22.07% growth. Insulet had revenue of $597.50M in the quarter ending December 31, 2024, with 17.20% growth.
Revenue (ttm)
$2.07B
Revenue Growth
+22.07%
P/S Ratio
8.75
Revenue / Employee
$531,179
Employees
3,900
Market Cap
18.17B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.07B | 374.50M | 22.07% |
Dec 31, 2023 | 1.70B | 391.80M | 30.02% |
Dec 31, 2022 | 1.31B | 206.50M | 18.79% |
Dec 31, 2021 | 1.10B | 194.40M | 21.49% |
Dec 31, 2020 | 904.40M | 166.20M | 22.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionPODD News
- 9 days ago - Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections - Business Wire
- 10 days ago - Insulet Announces Pricing of Senior Notes Due 2033 - Business Wire
- 10 days ago - Insulet Announces Proposed Financing Transactions - Business Wire
- 11 days ago - Insulet Leans Bullish (Technical Analysis) - Seeking Alpha
- 18 days ago - Insulet to Host Investor Day on June 5, 2025 - Business Wire
- 4 weeks ago - Insulet Sales Keep Rising - FXEmpire
- 5 weeks ago - Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst - Benzinga
- 5 weeks ago - Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript - Seeking Alpha